Directorate Change

Source: RNS
RNS Number : 1243I
Reckitt Benckiser Group PLC
19 March 2018
 

                       

 

 

 

 

 

 

 

 

Ken Hydon and Judy Sprieser to Retire

&

Appointment of Andrew Bonfield to the RB Board of Directors

 

 

19 March 2018 - Slough, UK - Reckitt Benckiser Group plc (RB), today announces that Ken Hydon and Judy Sprieser have confirmed that they will retire from the Board following the Annual General Meeting on 3 May 2018. As previously announced, Adrian Bellamy will also retire as Chairman and a member of the Board, to be succeeded by Chris Sinclair.

Ken has been a member of the Board since December 2003 and was Chair of the Audit Committee from November 2006 until May 2017. Judy has been a member of the Board since August 2003 and was Chair of the Remuneration Committee from June 2004 until November 2017.

Adrian Bellamy, Chairman, commented: "Ken and Judy have provided extraordinary service to the Board over many years. They have been part of the journey of transformation of RB which has created significant value for shareholders. On behalf of the entire Board, I would like to express my appreciation for their contribution and support to the company. As previously announced, I will also be stepping down from the Board at this year's AGM. It has been my great privilege to lead the Board and I believe that Chris Sinclair will do an excellent job as Chairman in the next phase of RB's transformation."

Andrew Bonfield has been appointed to the Board with effect from 1 July 2018, and will join the Audit Committee at that time. Andrew is currently CFO at National Grid Plc. and has served in that role since 2010. Prior to that, Andrew held roles as CFO at Cadbury Plc, Bristol-Myers Squibb, BG Group plc and SmithKline Beecham plc. He will shortly be stepping down as a non-executive director and Chair of the Audit Committee of Kingfisher plc, where he has served on the Board for eight years.

Chris Sinclair, Chairman-elect, said: "I would also like to thank Ken and Judy for their service and to reiterate my appreciation to Adrian, whom I am honoured to follow as Chairman of RB. I am also delighted that Andrew, who brings a wealth of financial and business experience, has agreed to join the Board. I am confident he will make a strong contribution to RB."

Chris Sinclair will also join the Corporate Responsibility, Sustainability, Ethics and Compliance Committee of the Board from 1 May 2018.

ABOUT RB

RB is the global leading consumer health, hygiene and home company. Driven by a purpose to build healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, our global brands help people live healthier, happier lives.

 

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit  Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence are manifested in the work of over 40,000 RB employees worldwide.

           

            Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

For further information, please contact:

RB

Richard Joyce

SVP, Investor Relations

Patty O'Hayer

Director, External Relations and Government Affairs

 

+44 (0)1753 217800

Finsbury (Financial PR)

Adam Atashzai

 

 

  +44 (0) 20 7251 3801



 

                                                                                                        


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUUAWUPRUBB